Test ID: 703

Test-Substance: CBD

Comet Assay CBD (included in test described under Test ID 702.):

  • Test: Genotoxicity test – Comet assay
  • Guideline: OECD Test Guideline No. 489
  • Testing Facility: Academic study / GLP compliant
  • Date of Testing: 12/2020 - 02/2021
  • Test-Substance: -(-) trans Cannabidiol, synthesized

Summary: This test was included in the 90-day oral toxicity study. In accordance with OECD Test Guideline No. 489, no signs of genotoxicity were observed at a GLP-compliant test facility at a dose of 0.66 mg/kg/day.

Categorisation according to Klimisch et al. 1997: "reliable without restriction"

The following price (net) is requested by the study owner: 60 000€ (incl. Test ID 702: 90-day subchronic toxicity study with CBD, Test ID 704: BRMT-Test with CBD)